Galapagos NV financials
Also U.S.-listed. Galapagos NV is also a foreign private issuer filing with the U.S. SEC. View its EDGAR financials: LKFT — GALAPAGOS NV
Galapagos NV
Country: BE Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
549300QKJ78IY0IOV655 Financial statements
(EUR, as reported — unscaled; 98 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €1.11B | €275.6M |
| Cost of sales | €29.7M | €34.9M |
| Other income | €53.5M | €40.8M |
| Operating profit (EBIT) | €295.0M | -€188.3M |
| Profit before tax | €300.9M | -€3.1M |
| Income tax expense | -€18.6M | -€1.8M |
| Profit for the year | €320.9M | €74.1M |
| — attributable to owners | €320.9M | €74.1M |
| Total comprehensive income | €314.9M | €81.5M |
| Per share | ||
| Basic EPS | €4.87 | €1.12 |
| Diluted EPS | €4.87 | €1.12 |
| Free cash flow / share | €-4.12 | €-5.09 |
| Cash flow statement | ||
| Cash generated from operations | -€307.9M | -€417.3M |
| Net cash from operating activities | -€257.5M | -€320.0M |
| Net cash from investing activities | €288.8M | €220.6M |
| Purchase of PP&E (capex) | €13.7M | €16.7M |
| Purchase of intangibles | €155.0K | €65.4M |
| Net cash from financing activities | -€3.3M | -€4.9M |
| Lease liability payments | €3.3M | €4.9M |
| Net change in cash | €28.1M | -€104.4M |
| Balance sheet | ||
| Total assets | €3.41B | €4.14B |
| Non-current assets | €327.1M | €796.3M |
| Intangible assets & goodwill | €0 | €70.0M |
| Current assets | €3.08B | €3.34B |
| Inventories | €22.5M | €51.2M |
| Trade & other receivables | €20.7M | €47.5M |
| Cash & equivalents | €87.9M | €64.2M |
| Total equity | €3.24B | €2.90B |
| Non-current liabilities | €17.8M | €903.7M |
| Lease liabilities (non-current) | €5.2M | €8.2M |
| Current liabilities | €152.9M | €335.1M |
| Lease liabilities (current) | €1.7M | €3.5M |
| Trade & other payables | €104.6M | €98.9M |
| Deferred tax liabilities | €0 | €20.7M |
| Derived metrics | ||
| Free cash flow | -€271.2M | -€336.7M |
| Operating margin | 26.5% | -68.3% |
| Net margin | 28.9% | 26.9% |
| Return on equity | 9.9% | 2.6% |
| Cash conversion ratio | -0.80× | -4.32× |
| Capex coverage | -18.79× | -19.14× |
| Other reported items | ||
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €228.1M | €0 |
| Adjustments For Increase Decrease In Deferred Income Other Than Contract Liabilities | -€1.07B | -€255.5M |
| Adjustments For Provisions | €45.5M | €0 |
| Basic Earnings Loss Per Share From Continuing Operations | €4.85 | €-0.02 |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €20.0M | — |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €87.9M | €64.2M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €19.4M | -€8.9M |
| Comprehensive Income Attributable To Owners of Parent | €314.9M | €81.5M |
| Comprehensive Income From Continuing Operations | €313.5M | €1.8M |
| Comprehensive Income From Discontinued Operations | €1.4M | €79.7M |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €3.08B | €3.33B |
| Current Deferred Income Other Than Current Contract Liabilities | €32.0K | €232.5M |
| Current Investments | €2.91B | €3.05B |
| Current Provisions | €45.5M | €0 |
| Current Tax Liabilities | €956.0K | €249.0K |
| Deferred Tax Assets | €195.0K | €1.5M |
| Diluted Earnings Loss Per Share From Continuing Operations | €4.85 | €-0.02 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€4.5M | €1.8M |
| Equity and Liabilities | €3.41B | €4.14B |
| Fair Value of Investments In Equity Instruments Designated As Measured At Fair Value Through Other Comprehensive Income | €46.8M | €52.9M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€475.0K | €578.0K |
| General and Administrative Expense | €147.3M | €117.2M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €228.1M | €0 |
| Income Taxes Paid Refund Classified As Operating Activities | €372.0K | -€406.0K |
| Increase Decrease Through Sharebased Payment Transactions | €24.0M | €19.9M |
| Intangible Assets Other Than Goodwill | €848.0K | €164.9M |
| Interest Paid Classified As Operating Activities | €464.0K | €689.0K |
| Interest Received Classified As Investing Activities | €60.4M | €29.5M |
| Interest Received Classified As Operating Activities | €51.3M | €97.5M |
| Issued Capital | €293.9M | €293.9M |
| Liabilities | €170.7M | €1.24B |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | €0 | €11.1M |
| Noncurrent Deferred Income Other Than Noncurrent Contract Liabilities | €0 | €838.9M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €0 | €2.1M |
| Other Adjustments For Noncash Items | €127.2M | -€4.9M |
| Other Adjustments For Which Cash Effects Are Investing Or Financing Cash Flow | -€42.3M | -€76.2M |
| Other Comprehensive Income | -€6.0M | €7.4M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -€6.1M | €2.5M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €653.0K | €246.0K |
| Other Current Assets | €7.0M | €31.0M |
| Other Finance Cost | €2.9M | €1.7M |
| Other Finance Income | €48.1M | €91.1M |
| Other Noncurrent Assets | €3.0M | €8.7M |
| Other Noncurrent Financial Assets | €0 | €200.2M |
| Other Noncurrent Liabilities | €12.6M | €33.8M |
| Other Reserves | -€8.6M | -€3.2M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €462.0K | €3.0K |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €3.68B | €3.67B |
| Profit Loss From Continuing Operations | €319.5M | -€1.3M |
| Profit Loss From Discontinued Operations | €1.4M | €75.4M |
| Purchase of Financial Assets Measured At Fair Value Through Other Comprehensive Income Classified As Investing Activities | €0 | €36.9M |
| Purchase of Financial Instruments Classified As Investing Activities | €3.47B | €3.35B |
| Reclassification Adjustments On Exchange Differences On Translation Net of Tax | €0 | -€4.1M |
| Research and Development Expense | €459.4M | €335.5M |
| Reserve of Exchange Differences On Translation | €3.0M | €3.5M |
| Retained Earnings | €210.6M | -€134.3M |
| Sales and Marketing Expense | €6.1M | €17.2M |
| Share Premium | €2.74B | €2.74B |
Methodology
Every line item above is a fact tagged in Galapagos NV's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.